Adult Immunization

Latest News

Data for Arexvy Show Vaccine Efficacy Through 3 RSV Seasons in Older Adults/ image credit - gsk logo: ©desertsands/stock.adobe.com
New Data for Arexvy Show Vaccine Efficacy Through 3 RSV Seasons in Older Adults

October 9th 2024

Data on adults aged 60 years and older who received a single dose of the RSV vaccine indicate safety and reactogenicity consistent with the overall GSK phase 3 trial program.

RSV Mortality Higher than for Influenza B 90 Days After Hospital Discharge: New Data / image credit - flu and rsv viruses: ©Kateryna_Kon/stock.adobe.com
RSV Mortality Higher than for Influenza B 90 Days After Hospital Discharge: New Data

October 1st 2024

More than One-Third of US Adults Say They "Don't Need" Respiratory Virus Vaccines this Fall
More than One-Third of US Adults Say They "Don't Need" Respiratory Virus Vaccines this Fall

September 23rd 2024

RSV Vaccine Effective Against Hospitalization in Older Adults: Daily Dose / image credit: ©New Africa/AdobeStock
RSV Vaccine Effective Against Hospitalization in Older Adults: Daily Dose

September 23rd 2024

ACIP Highlights Evidence Supporting Recommendation for PCV21 Vaccine for Adults / Image credit: ©Crystal Light/AdobeStock
ACIP Highlights Evidence Supporting Recommendation for PCV21 Vaccine for Adults

September 20th 2024

Latest CME Events & Activities

Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations

View More

<123456
© 2024 MJH Life Sciences

All rights reserved.